US 12,735,594

Application 18/285,838 · Granted Sep 15, 2026

Printing ink

Estimated expiration

December 9, 2042

16y 22d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTGB2022050869: Resource not found (404)
Earliest effective filing
Apr 7, 2022
+ 20 years
Apr 7, 2042
PTA +246d
Dec 9, 2042
No TD
—
Final
Dec 9, 2042

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
October 5, 2023
Earliest effective filing
April 7, 2022
Issue date
September 15, 2026
PTA
+246 days
Base expiry (before PTA)
April 7, 2042

April 7, 2022 + 20 years = April 7, 2042 + 246 PTA days = December 9, 2042

  • National stage entry of application PCTGB2022050869, filed Apr 7, 2022

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 18/285,838 · US 12,735,594

PatentReply compiles the prosecution history behind US 12,735,594: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12735594

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.